Literature DB >> 2217007

Nephrology, dialysis and transplantation.

K Farrington1, P Sweny.   

Abstract

Mesh：

Year:  1990        PMID： 2217007      PMCID： PMC2429640          DOI： 10.1136/pgmj.66.777.502

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  209 in total

Review 1.  Clinical disorders of renal tubular phosphate transport.

Authors:  M Levi
Journal:  Am J Med Sci       Date:  1989-09       Impact factor: 2.378

Review 2.  Parathyroid hormone and 1,25(OH)2D3 in chronic renal failure.

Authors:  D A Feinfeld; L M Sherwood
Journal:  Kidney Int       Date:  1988-06       Impact factor: 10.612

3.  Elimination of beta 2-microglobulin by a new polyacrylonitrile membrane dialyser: mechanism and physiokinetics.

Authors:  T Akizawa; S Koshikawa; R Nakazawa; T Yoshida; M Kaneko; Y Nitadori
Journal:  Nephrol Dial Transplant       Date:  1989       Impact factor: 5.992

Review 4.  Mucormycosis: association with deferoxamine therapy.

Authors:  A L Daly; L A Velazquez; S F Bradley; C A Kauffman
Journal:  Am J Med       Date:  1989-10       Impact factor: 4.965

Review 5.  Ammonium excretion in chronic metabolic acidosis: benefits and risks.

Authors:  M L Halperin; J H Ethier; K S Kamel
Journal:  Am J Kidney Dis       Date:  1989-10       Impact factor: 8.860

6.  FK 506 for liver, kidney, and pancreas transplantation.

Authors:  T E Starzl; S Todo; J Fung; A J Demetris; R Venkataramman; A Jain
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

7.  Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy.

Authors:  H H Parving; E Hommel; M Damkjaer Nielsen; J Giese
Journal:  BMJ       Date:  1989-08-26

8.  Renal mesangium is a target for calcitonin gene-related peptide.

Authors:  A Kurtz; H J Schurek; W Jelkmann; R Muff; H P Lipp; U Heckmann; K U Eckardt; H Scholz; J A Fischer; C Bauer
Journal:  Kidney Int       Date:  1989-08       Impact factor: 10.612

9.  Desferrioxamine therapy in hemodialysis patients with aluminum-associated bone disease.

Authors:  A J Felsenfeld; M Rodriguez; M Coleman; D Ross; F Llach
Journal:  Kidney Int       Date:  1989-06       Impact factor: 10.612

10.  Elective total parathyroidectomy without autotransplant in end-stage renal disease.

Authors:  M Kaye; P D'Amour; J Henderson
Journal:  Kidney Int       Date:  1989-06       Impact factor: 10.612
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.